[European protocol for the management of fetal supraventricular tachycardia. European Association of Pediatric Cardiology].
Azancot-Benisty
A
A
Unité de cardiologie prénatale, hôpital Rober-Debre, Paris.
Areias
J C
JC
Oberhänsli
I
I
Schmidt
K G
KG
Tulzer
G
G
Viart
P
P
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D004077:Digoxin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D005313:Fetal Death / Q000209:etiology; D005315:Fetal Diseases / Q000175:diagnosis* / Q000188:drug therapy*; D005424:Flecainide / Q000627:therapeutic use*; D005865:Gestational Age; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D015160:Hydrops Fetalis / Q000209:etiology; D007231:Infant, Newborn; D011247:Pregnancy; D013617:Tachycardia, Supraventricular / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D016216:Ultrasonography, Prenatal
D000889:Anti-Arrhythmia Agents; D004077:Digoxin; D005424:Flecainide